Inflammatory Cell Profiles in Early- and Late-Manifestation Immune Checkpoint Inhibitor Myocarditis

JACC CardioOncology 2026 Open access

Read full text
Authors: Kazuaki Maruyama, Yudai Tamura, Shiro Nakamori, Kazuko Tajiri, Hirofumi Tomita, Koichiro Kinugawa, Ryota Morimoto, Hiroshi Akazawa, Toshihiro Tsuruda, Michiro Maruyama, Yuichi Miyake, Hiroaki Kawano
+5 more Michiaki Hiroe, Kaoru Dohi, Kyoko Imanaka-Yoshida, Issei Komuro, Yuichi Tamura
DOI: 10.1016/j.jaccao.2026.07.008
Cited by: 1
References: 25

Abstract

BACKGROUND: Immune checkpoint inhibitor (ICI) myocarditis typically develops soon after treatment initiation (

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Viral Infections and Immunology Research Pericarditis and Cardiac Tamponade

Publication details

Journal / source
JACC CardioOncology
Publisher
Elsevier BV
Volume
8
Issue
5
Pages
518-529
Publication date
1 August 2026
Language
EN